🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseAlcohol + MASH + GLP-1 — July 2024 Page 3

Alcohol + MASH + GLP-1 — July 2024

carlos_SATX Sun, Oct 19, 2025 at 3:58 PM 44 replies 1,456 viewsPage 3 of 9
COA_Karl
Senior Member
2,123
8,901
Jan 2024
Pennsylvania
Oct 23, 2025 at 2:43 PM#11
TrialTracker_MD said:
The version of this that has an answer is narrower than the version being asked.

Correct as far as it goes. The part it does not cover is what to do when the honest answer is "not enough data", which is more often than anyone likes.

Worth separating that from liver and MASH, which this thread keeps folding into the same question. They behave differently and the advice does not transfer.

20 18matt_MKE, Dr.ReproEndo, lucas_SP_BR and 17 others
Reply Quote Save Share Report
GenomicsKate
Member
345
1,890
Oct 2024
Cambridge, MA
Oct 25, 2025 at 10:53 AM#12
JennaRN said:
Agreed, and ALT falling is not the same as fibrosis improving.

Thank you for spelling out the reasoning rather than just the conclusion.

21 19KristenIndy, MarkLI_maint, Dr.PeteFamMed and 18 others
Reply Quote Save Share Report
MounjBrad
Member
278
890
Oct 2024
Kentucky
Oct 27, 2025 at 7:02 AM#13
TrialTracker_MD said:
The version of this that has an answer is narrower than the version being asked.

I read this differently from TrialTracker_MD, on substance rather than tone. Not convinced. The evidence being cited is consistent with the conclusion and also consistent with two other conclusions nobody has ruled out.

22 20nick_SD_fit, ben_calgary, patPC_UT and 19 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
Dr.PulmRoch
Member
456
2,345
Jun 2024
Rochester, MN
Oct 29, 2025 at 3:10 AM#14

One concrete data point for the thread. The boring version of this is the one that works, and the boring version is: measure a baseline, change one variable, wait, measure again under the same conditions. Nobody wants that answer and it is still the answer.

23 21DebRD_ATL, KristenIndy, MarkLI_maint and 20 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Oct 30, 2025 at 11:17 PM#15

Moderator note: leaving this open. It is being argued well and the disagreement is the useful part. No action needed from anybody.

24 22PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 21 others
Reply Quote Save Share Report

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register